Terbutaline (beta-andrenergic agonist) as a uterine smooth muscle relaxant to treat endometriosis
Other
OA: closed
AI-generated summary
This patent describes compositions and methods for using terbutaline to locally treat endometriosis, infertility, and enhance fertility while minimizing systemic side effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Described are compositions and methods for using a beta -adrenergic agonist for treating endometriosis, for treating infertility, and for enhancing fertility. Further described is the formulating such a composition or method in such a way as to provide therapeutically sufficient levels of the beta -adrenergic agonist locally while avoiding adverse systematic concentrations in the host, thereby minimising or avoiding adverse side effects.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-25T09:32:14.900964+00:00